Transcriptome profiling further revealed that ChREBP expression was specifically increased in HCC from patients with chronic liver diseases including viral HCV infection, NAFLD and NASH etiologies (Supplementary Fig. 1a, b). The gene discussed is MLXIPL; the disease is metabolic dysfunction-associated steatohepatitis.